All Ashley Tuan Articles
-
101Products & ServicesDr. Ashley Tuan Discusses VTI’s PROTECT Trial
sponsored content October 17, 2023 Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Ashley Tuan, OD, PhD, Chief Medical Officer of Visioneering Technologies...
-
240Latest Myopia NewsVTI Shares One-Year Data from PROTECT Trial at AAO 2023
October 12, 2023 NEW ORLEANS, La. — At the 2023 American Academy of Optometry meeting held here, Visioneering Technologies Inc. shared interim...
-
529Latest Myopia NewsVTI’s NaturalVue Six-Year Data Confirmed by Three Independent Studies
September 8, 2023 CHICAGO — Visioneering Technologies Inc. completed a six-year clinical trial for its NaturalVue Multifocal (MF) contact lenses, and now,...
-
693Latest Myopia NewsVTI’s PROTECT Study Reaches 100% Enrollment
December 7, 2022 ATLANTA — Visioneering Technologies Inc.’s PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study has officially reached 100% participant enrollment....
-
1.1KClinicalWhat Can Chicken Eyes Tell Us About Using NaturalVue Multifocals?
sponsored content August 1, 2022 By Ashley Tuan, OD, PhD, FAAO Randomized controlled chicken studies have shown relative myopic defocus from a...
-
793Latest Myopia NewsVTI Reaches 50% Enrollment Milestone for PROTECT Study
July 13, 2022 ATLANTA – Medical device company and producer of NaturalVue Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX:VTI) announced...
-
802Latest Myopia NewsVTI’s Six-Year Clinical Trial Data Published in Clinical Ophthalmology
July 8, 2022 ATLANTA — Findings from Visioneering Technologies Inc.’s (VTI) six-year myopia management clinical trial were published in the Clinical Ophthalmology journal. The study...
-
884Clinical
VTI’s CMO Dr. Ashley Tuan On NaturalVue and the PROTECT Study
sponsored content April 1, 2022 We believe that for myopia management, there needs to be a lot of tools in [the practitioner’s]...
-
1.7KProducts & ServicesVTI’s CMO Dr. Ashley Tuan on NaturalVue and the PROTECT Study
sponsored content March 15, 2022 Visioneering Technologies Inc. (VTI) has launched an international clinical trial that will test the efficacy of its...
-
1.6KLatest Myopia NewsVTI Begins International Myopia Control Clinical Trial of NaturalVue Lenses
January 24, 2022 ATLANTA — Visioneering Technologies Inc. announced that it has begun its international clinical trial that is designed to test...
-
2.2KLatest Myopia NewsVTI Releases NaturalVue Data, Unveils Enhanced Multifocal, and Names CMO
November 4, 2021 BOSTON — During a press event at the American Academy of Optometry’s (AAO) 2021 meeting, Visioneering Technologies Inc. (VTI)...